1.030GBp-1.90%Mkt Cap: 24.16M GBpP/E: —Last update: 2026-06-01
Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. The company offers syrup and powder versions of Fruitflow, a tomato extract …
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap24.16M GBp
Enterprise Value23.57M GBp
Revenue (TTM)871.26K GBp
Gross Profit532.94K GBp
Net Income (TTM)-452.72K GBp
Revenue/Share0.0000 GBp
Last Price1.030 GBp
Fiscal Year EndMar 2025
MR QuarterSep 2025
Employees2
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue27.06
P/S28.27
P/B—
EPS (TTM)0.00
EPS (Forward)—
52W Range
0.006266% of range1.550
52W High1.550 GBp
52W Low0.0062 GBp
Profitability
Gross Margin41.24%
Oper. Margin-85.00%
EBITDA Margin0.00%
Profit Margin-35.03%
ROE-34.89%
ROA-44.73%
Growth
Revenue Growth-53.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-340.83K GBp
CapEx (TTM)—
FCF Margin-37.23%
FCF Yield-1.34%
Net Debt-523.35K GBp
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio3.65
Quick Ratio3.46
Book Value/Sh0.0000 GBp
Cash/Share0.0000 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateJun 23, 2005
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.35B
Float1.81B
Insiders20.03%
Institutions8.91%
Technical
SMA 501.025 (+0.5%)
SMA 2000.8489 (+21.3%)
Beta0.66
S&P 52W Chg27.94%
Avg Vol (30d)1.57M
Avg Vol (10d)2.81M
Technical Indicators
RSI (14)53.7
MACD0.0046
MACD Signal-0.0066
MACD Hist.+0.0112
BB Upper1.103 GBp
BB Middle1.016 GBp
BB Lower0.9296 GBp
BB Width17.09%
ATR (14)0.1894 GBp
Vol Ratio (20d)0.23x